Infectosoor Zinksalbe (Miconazole Nitrate, Zinc Oxide)

Miconazole nitrate inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for ergosterol synthesis. Without ergosterol, the fungal cell membrane becomes compromised, leading to cell death. Zinc oxide adds a protective layer and mild anti‑inflammatory effect, supporting the antifungal action.

The dosage of Infectosoor Zinksalbe is determined by the prescribing healthcare professional based on the infection’s location and severity. Typically, a thin layer is applied to the affected skin area once or twice daily, but the exact regimen should follow the prescriber’s instructions.

Safety data for Infectosoor Zinksalbe in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using the product.

To order Infectosoor Zinksalbe, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent antifungal creams, Infectosoor Zinksalbe offers the dual benefit of miconazole’s broad‑spectrum fungicidal activity and zinc oxide’s barrier and anti‑inflammatory properties. This combination can enhance symptom relief and may be preferred for patients who need both antifungal and soothing effects.

Store Infectosoor Zinksalbe at ambient temperature, preferably below 25 °C. Keep the tube tightly closed in its original packaging, protect it from moisture and direct sunlight, and avoid freezing. Ensure the container is out of reach of children.

The ointment is applied topically to clean, dry skin. A thin layer should be spread over the affected area and gently rubbed in. Depending on the prescriber’s advice, the area may be left uncovered or covered with a non‑occlusive dressing.

The most serious risks include severe allergic reactions such as angioedema, widespread contact dermatitis, and rare skin ulceration. If any signs of systemic allergy (e.g., swelling of the face, difficulty breathing) or severe skin changes occur, discontinue use and seek immediate medical attention.

Individuals with known hypersensitivity to miconazole nitrate, zinc oxide, or any excipients in the formulation should avoid using Infectosoor Zinksalbe. It is also contraindicated on mucous membranes, open wounds, or in patients where a systemic antifungal is required without medical supervision.